Abstract:Cytotoxic T lymphocytes and NK cells play an important role in eliminating malignant tumor cells and the number and activity of tumor-infiltrating T cells represent a good marker for tumor prognosis. Based on these findings, immunotherapy, e.g., checkpoint blockade, has received considerable attention during the last couple of years. However, for the majority of patients, immune control of their tumors is gray theory as malignant cells use effective mechanisms to outsmart the immune system. Increasing evidence suggests that changes in tumor metabolism not only ensure an effective energy supply and generation of building blocks for tumor growth but also contribute to inhibition of the antitumor response. Immunosuppression in the tumor microenvironment is often based on the mutual metabolic requirements of immune cells and tumor cells. Cytotoxic T and NK cell activation leads to an increased demand for glucose and amino acids, a well-known feature shown by tumor cells. These close metabolic interdependencies result in metabolic competition, limiting the proliferation, and effector functions of tumor-specific immune cells. Moreover, not only nutrient restriction but also tumor-driven shifts in metabolite abundance and accumulation of metabolic waste products (e.g., lactate) lead to local immunosuppression, thereby facilitating tumor progression and metastasis. In this review, we describe the metabolic interplay between immune cells and tumor cells and discuss tumor cell metabolism as a target structure for cancer therapy. Metabolic (re)education of tumor cells is not only an approach to kill tumor cells directly but could overcome metabolic immunosuppression in the tumor microenvironment and thereby facilitate immunotherapy.

The interplay between metabolic adaptations and diet in cancer immunotherapy

Altered cancer metabolism in mechanisms of immunotherapy resistance

Targeting Metabolism to Improve the Tumor Microenvironment for Cancer Immunotherapy

Metabolic modulation of immune checkpoints and novel therapeutic strategies in cancer

Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment

Targeting Tumor Metabolism: A New Challenge to Improve Immunotherapy

Cancer cell metabolic reprogramming: a keystone for the response to immunotherapy

Immuno-Metabolism: The Role of Cancer Niche in Immune Checkpoint Inhibitor Resistance

Metabolic interventions: A new insight into the cancer immunotherapy

Metabolic Interplay in the Tumor Microenvironment: Implications for Immune Function and Anticancer Response

Metabolic rewiring and communication in cancer immunity

Cancer Cell Metabolism Bolsters Immunotherapy Resistance by Promoting an Immunosuppressive Tumor Microenvironment

Metabolic Crosstalk in the Tumor Microenvironment Regulates Antitumor Immunosuppression and Immunotherapy Resisitance.

Targeting metabolism to enhance immunotherapy within tumor microenvironment

Tumor-intrinsic metabolic reprogramming and how it drives resistance to anti-PD-1/PD-L1 treatment

Metabolic reprogramming and immune evasion: the interplay in the tumor microenvironment

Metabolic Implications of Immune Checkpoint Proteins in Cancer

Immunological Aspects of Cancer Cell Metabolism

Metabolic Modifications, Inflammation, and Cancer Immunotherapy

Immunometabolism: a new dimension in immunotherapy resistance